retatrutide approval status 2025 fda ema The 'Miracle Drug' and the Peptide Craze Breaking the Retatrutide produces up to 30.3%

These factors alone make this a high-risk period for the return or development of disordered eating and body image distress

The key is staying in communication with your prescriber rather than trying to self-adjust either medication

The people who could benefit most from these medications are often those least able to afford them, perpetuating a cycle in which geography, income, and health outcomes remain tightly intertwined

Lee SH, Ko HM, Jee W, Kim H, Chung WS, Jang HJ

June 6, 2025: Novo Nordisk Asked to Add NAION, Which Can Cause Blindness, to Ozempic Warning Label The European Medicines Agency has concluded that taking Ozempic and other medications that contain semaglutide may increase someones risk of developing NAION

The optimal timing for GLP-1 injections depends primarily on the specific formulation you have been prescribed, rather than a universal rule applying to all GLP-1 medications